Bank of Nova Scotia’s Athenahealth, Inc. ATHN Stock Holding History

Bank of Nova Scotia’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-283,600	Closed	-$37.4M	–	954
2018 Q4	$37.4M	Buy	283,600 +86,699	+44%	+$11.1M	0.18%	123
2018 Q3	$26.3M	Buy	196,901 +140,001	+246%	+$21M	0.12%	167
2018 Q2	$9.05M	Sell	56,900 -93,100	-62%	-$13.8M	0.05%	263
2018 Q1	$21.5M	Buy	150,000 +116,000	+341%	+$15.9M	0.11%	180
2017 Q4	$4.52M	Sell	34,000 -20,000	-37%	-$2.56M	0.02%	419
2017 Q3	$6.71M	Buy	+54,000	New	+$7.44M	0.04%	320

Bank of Nova Scotia's ATHN Position: Q1 2019 in Review

Bank of Nova Scotia sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 283,600 shares — an estimated $37.4M sold.

Bank of Nova Scotia first reported a position in ATHN in Q3 2017 and held it in 6 quarters. The position peaked at $37.4M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Bank of Nova Scotia reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Bank of Nova Scotia sold 283,600 Athenahealth, Inc. shares in Q1 2019, an estimated $37.4M.
Bank of Nova Scotia first reported a position in Athenahealth, Inc. in Q3 2017 and held it in 6 quarters.
Bank of Nova Scotia's Athenahealth, Inc. position peaked at $37.4M in Q4 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Bank of Nova Scotia's 13F filing for Q1 2019, filed 15 May 2019.